000			05160cam a2200601 i 4500
001			9781003002499
003			FlBoTFG
005			20211012173307.0
006			m o d
007			cr |||||||||||
008			201012t20212021flua o 000 0 eng d
040			_aOCoLC-P _beng _erda _epn _cOCoLC-P
020			_a9781000263657 _qelectronic book
020			_a1000263657 _qelectronic book
020			_a9781000263572 _qelectronic book
020			_a1000263576 _qelectronic book
020			_a9781003002499 _qelectronic book
020			_a1003002498 _qelectronic book
020			_a9781000263497 _qelectronic book
020			_a1000263495 _qelectronic book
020			_z9780367433352 _qhardcover
020			_z9780367432447 _qpaperback
024	7		_a10.4324/9781003002499 _2doi
035			_a(OCoLC)1202911344
035			_a(OCoLC-P)1202911344
050		4	_aHD9666.6 _b.S65 2021
072		7	_aBUS _x071000 _2bisacsh
072		7	_aMED _x002000 _2bisacsh
072		7	_aMED _x036000 _2bisacsh
072		7	_aKJMB _2bicssc
082	0	4	_a338.4/761510973 _223
100	1		_aSmith, Mickey C., _eauthor.
245	1	0	_aGovernment, big pharma, and the people : _ba century of dis-ease / _cMickey C. Smith ; with E.M. (Mick) Kolassa and Walter Steven Pray.
264		1	_aBoca Raton, FL : _bRoutledge, _c2021.
264		4	_c©2021
300			_a1 online resource (xxiv, 475 pages) : _billustrations
336			_atext _btxt _2rdacontent
336			_astill image _bsti _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
500			_a"A Productivity Press Book" -- Title Page.
520			_aPharmaceuticals constitute a relatively small share of the total Health Care expenditure in most developed economies, and yet they play a critical role in the ongoing debate over how best to advance, improve, and afford Health Care. Despite this, and perhaps because of this, the industry has had, for many years, an outsized claim to fame and controversy, praise and criticisms, and support and condemnation. Unfortunately, many participants in the debate do not fully understand the complexities of the industry and its role in the overall Health Care system. The analytical tools of economics provide a strong foundation for a better understanding of the dynamics of the pharmaceutical industry, its contribution to Health and Health Care, and its dual and often conflicting priorities of affordability and innovation, as well as the variousPrivate and Public Policy initiatives directed at the sector. Everyone is affected by Big Pharma and the products they produce. At the Drug store, the physician's office, in front of the television, in everyday conversations, Drugs are a part of our lives. Society shapes our values toward Drugs and Drugs shape society. ("The Pill" and minor tranquilizers are good examples.) And, of course, the way Congress deliberates and Big Pharma responds has a huge impact on how Drugs affect our lives. This book is well-researched on the subject of the pharmaceutical industry, its struggles with Government, and its relationship to the consumer from the early twentieth century until the present. The Dynamic Tension between the three participants - Government, Big Pharma, and the People - is described and explained to lead to an understanding of the controversies that rage today. The author describes how the Government, its many investigatory efforts, and the ultimate legislative results affect the industry and the consequences of their activities are explored in light of their effects on other players, including the patients and consumers who rely on both Government and Big Pharma for their well-being and who find sometimes unexpected consequences while giving special attention to the attitudes, beliefs, and misadventures of less-than-optimal Drug use. Stakeholders are identified with physicians as a major focus, as well as describing the significance of prescriptions as social objects and the processes by which physicians make choices on behalf of their patients. The author ties it all together with how Big Pharma affects and is affected by each of these groups. The author utilizes his 50-plus years' experience as an academic, practicing pharmacist, and Big Pharma employee to describe the scope of the pharmaceutical industry and how it affects us on a daily basis, concluding with an inside look at Big Pharma and how regulations, marketing, and the press have affected their business, both good and bad.
588			_aOCLC-licensed vendor bibliographic record.
650		0	_aPharmaceutical industry _xGovernment policy _zUnited States.
650		0	_aPharmaceutical policy _zUnited States.
650		0	_aMedical policy _zUnited States.
650		0	_aDrugs _xLaw and legislation _zUnited States.
650		7	_aBUSINESS & ECONOMICS / Leadership _2bisacsh
650		7	_aMEDICAL / Administration _2bisacsh
650		7	_aMEDICAL / Health Policy _2bisacsh
856	4	0	_3Taylor & Francis _uhttps://www.taylorfrancis.com/books/9781003002499
856	4	2	_3OCLC metadata license agreement _uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
999			_c549467 _d549402